• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

病例报告:COVID-19 再激活病例。

Case report: a COVID-19 reactivation case.

机构信息

Department of Anesthesiology and Critical Care, University Hospital Ibn Rochd, Casablanca, Morocco.

出版信息

Pan Afr Med J. 2020 May 15;35(Suppl 2):35. doi: 10.11604/pamj.supp.2020.35.2.23326. eCollection 2020.

DOI:10.11604/pamj.supp.2020.35.2.23326
PMID:33623560
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7875717/
Abstract

The novel Coronavirus, named SARS-COV-2, is responsible of the COVID-19. It is a viral pneumonia that appeared in December 2019 in Wuhan, China, and is causing a pandemic. Most of patients present mild symptoms, but in many other patients, acute respiratory distress (ARDS) is more likely to be developped. The actual problematic is the appearance of cases with virus reactivation. We report a case of virus reactivation in a COVID-19 patient with ARDS.

摘要

新型冠状病毒(SARS-CoV-2)引发了 COVID-19 肺炎。这种病毒于 2019 年 12 月在中国武汉出现,引发了全球大流行。大多数患者症状较轻,但在许多其他患者中,更有可能发展为急性呼吸窘迫综合征(ARDS)。目前的问题是出现了病毒再激活的病例。我们报告了一例 COVID-19 合并 ARDS 患者的病毒再激活病例。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b19/7875717/a8df78467099/PAMJ-SUPP-35-2-35-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b19/7875717/2af876d0ae1e/PAMJ-SUPP-35-2-35-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b19/7875717/a8df78467099/PAMJ-SUPP-35-2-35-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b19/7875717/2af876d0ae1e/PAMJ-SUPP-35-2-35-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b19/7875717/a8df78467099/PAMJ-SUPP-35-2-35-g002.jpg

相似文献

1
Case report: a COVID-19 reactivation case.病例报告:COVID-19 再激活病例。
Pan Afr Med J. 2020 May 15;35(Suppl 2):35. doi: 10.11604/pamj.supp.2020.35.2.23326. eCollection 2020.
2
Therapeutic Potential of Mesenchymal Stem Cells and Their Secretome in the Treatment of SARS-CoV-2-Induced Acute Respiratory Distress Syndrome.间充质干细胞及其分泌组在治疗 SARS-CoV-2 诱导的急性呼吸窘迫综合征中的治疗潜力。
Anal Cell Pathol (Amst). 2020 Nov 20;2020:1939768. doi: 10.1155/2020/1939768. eCollection 2020.
3
NEUT-SFL in Patients with COVID-ARDS: A Novel Biomarker for Thrombotic Events?中性粒细胞胞外诱捕网在 COVID-ARDS 患者中的作用:血栓事件的新型生物标志物?
Dis Markers. 2021 Nov 17;2021:4361844. doi: 10.1155/2021/4361844. eCollection 2021.
4
Respiratory and ventilator management of COVID-19.新型冠状病毒肺炎的呼吸与通气管理
J Pak Med Assoc. 2020 May;70(Suppl 3)(5):S60-S63. doi: 10.5455/JPMA.23.
5
Acute respiratory distress syndrome (ARDS) caused by the novel coronavirus disease (COVID-19): a practical comprehensive literature review.新型冠状病毒病(COVID-19)所致急性呼吸窘迫综合征(ARDS):实用综合文献复习。
Expert Rev Respir Med. 2021 Feb;15(2):183-195. doi: 10.1080/17476348.2020.1820329. Epub 2020 Oct 18.
6
The rationale of using mesenchymal stem cells in patients with COVID-19-related acute respiratory distress syndrome: What to expect.在 COVID-19 相关急性呼吸窘迫综合征患者中使用间充质干细胞的基本原理:预期会有什么结果。
Stem Cells Transl Med. 2020 Nov;9(11):1287-1302. doi: 10.1002/sctm.20-0164. Epub 2020 Jul 21.
7
Management of crash and burn patients with SARS-CoV-2 associated ARDS.新型冠状病毒肺炎相关急性呼吸窘迫综合征(SARS-CoV-2 associated ARDS)重症患者的管理
J Card Surg. 2020 Sep;35(9):2129-2130. doi: 10.1111/jocs.14699. Epub 2020 Jul 14.
8
Central involvement of SARS-CoV-2 may aggravate ARDS and hypertension.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的中枢神经系统受累可能会加重急性呼吸窘迫综合征(ARDS)和高血压。
J Renin Angiotensin Aldosterone Syst. 2020 Oct-Dec;21(4):1470320320972015. doi: 10.1177/1470320320972015.
9
Δ9-Tetrahydrocannabinol Prevents Mortality from Acute Respiratory Distress Syndrome through the Induction of Apoptosis in Immune Cells, Leading to Cytokine Storm Suppression.Δ9-四氢大麻酚通过诱导免疫细胞凋亡,从而抑制细胞因子风暴,防止急性呼吸窘迫综合征导致的死亡。
Int J Mol Sci. 2020 Aug 28;21(17):6244. doi: 10.3390/ijms21176244.
10
Successful management of the first reported case in Austria of COVID-19 with ARDS.成功治疗奥地利首例伴有 ARDS 的 COVID-19 病例。
Infection. 2020 Aug;48(4):647-651. doi: 10.1007/s15010-020-01458-9. Epub 2020 Jun 13.

引用本文的文献

1
Clinical and epidemiological features of patients with COVID-19 reinfection: a systematic review.新冠病毒二次感染患者的临床和流行病学特征:一项系统综述
New Microbes New Infect. 2022 Jul;48:101021. doi: 10.1016/j.nmni.2022.101021. Epub 2022 Aug 28.
2
Clinical manifestations, treatment options, and comorbidities in COVID-19 relapse patients: A systematic review.COVID-19 复发患者的临床表现、治疗选择和合并症:系统评价。
J Clin Lab Anal. 2022 May;36(5):e24402. doi: 10.1002/jcla.24402. Epub 2022 Apr 8.

本文引用的文献

1
Clinical characteristics of severe acute respiratory syndrome coronavirus 2 reactivation.严重急性呼吸综合征冠状病毒 2 再激活的临床特征。
J Infect. 2020 May;80(5):e14-e17. doi: 10.1016/j.jinf.2020.03.001. Epub 2020 Mar 20.
2
Recurrence of positive SARS-CoV-2 RNA in COVID-19: A case report.COVID-19 中 SARS-CoV-2 RNA 复阳:一例报告。
Int J Infect Dis. 2020 Apr;93:297-299. doi: 10.1016/j.ijid.2020.03.003. Epub 2020 Mar 5.